Exact Sciences (EXAS) | Stock Overview & Key Data
Exact Sciences Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $159.54 on January 25, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Exact Sciences
EXAS
|
20.03B Large-cap | 1.02% | 1.47% | 3.27% | 100.17% | 3.12% | 140.29% | 54.71% | -20.87% | 1,407.33% | 1,337.12% | 3,317.26% |
|
Thermo Fisher
TMO
|
174.55B Large-cap | 0.87% | 8.07% | 0.79% | -17.74% | -20.05% | 16.53% | -12.65% | -2.72% | 220.94% | 654.32% | 1,231.84% |
|
Danaher
DHR
|
126.39B Large-cap | -1.32% | 11.85% | -5.38% | -20.75% | -21.40% | -10.25% | -15.98% | -20.94% | 174.08% | 416.93% | 738.84% |
|
Idexx Laboratories
IDXX
|
44.66B Large-cap | 1.57% | 7.79% | -2.79% | -18.64% | -14.92% | 7.30% | 16.12% | -6.68% | 539.84% | 1,431.62% | 2,795.61% |
| 32.65B Large-cap | -2.11% | 3.78% | 7.87% | -3.22% | -4.70% | 10.90% | 7.19% | -10.46% | 186.24% | 282.67% | 444.17% | |
|
Waters
WAT
|
30.55B Large-cap | -1.54% | 8.67% | 23.36% | -7.18% | -6.34% | 3.87% | 32.07% | 3.74% | 165.28% | 286.07% | 736.74% |
Ownership & Short Interest
Calculate Your Exact Sciences Investment Returns
Long-Term Investment Performance Analysis
Exact Sciences stock price in Jul 2016 was $12.48, A $1,000.00 lump sum investment in Exact Sciences made 9 years ago would be worth approximately $8,406.25 today, representing a exceptional return of 740.62%. This translates to an annualized return (CAGR) of 24.60%.
9 Years 8 Months Investment Scenario (Jul 2016 - Mar 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is EXAS's 52-week high and low?
- In the last 52 weeks, Exact Sciences reached a high of $104.98 (on March 20, 2026) and a low of $38.81 (on N/A).
- What is the market cap and P/E ratio for EXAS?
- Curious about Exact Sciences's size and valuation? Its market capitalization stands at 20.03B. When it comes to valuation, the P/E ratio (trailing twelve months) is -95.37, and the forward P/E (looking ahead) is 55.22.
- Does EXAS pay dividends? If so, what's the yield?
- As for dividends, Exact Sciences isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Exact Sciences's main competitors or similar companies to consider before investing?
When looking at Exact Sciences, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Thermo Fisher
TMO174.55B Healthcare Diagnostics & Research 16.53% -12.65% Danaher
DHR126.39B Healthcare Diagnostics & Research -10.25% -15.98% Idexx Laboratories
IDXX44.66B Healthcare Diagnostics & Research 7.30% 16.12% Agilent Technologies
A32.65B Healthcare Diagnostics & Research 10.90% 7.19% Waters
WAT30.55B Healthcare Diagnostics & Research 3.87% 32.07% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Exact Sciences Corp? (e.g., ROE, Debt/Equity)
- To get a sense of Exact Sciences's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -8.66%, the Debt to Equity ratio from the most recent quarter is 105.57, and its Gross Profit Margin stands at 70.11%.
- What is the recent revenue and earnings growth for EXAS?
- Looking at Exact Sciences's growth, its revenue over the trailing twelve months (TTM) was $3B. Compared to the same quarter last year (YoY), quarterly revenue grew by 23.10%, and quarterly earnings saw a YoY growth of 23.12%.
- How much of EXAS stock is held by insiders and institutions?
- Wondering who owns Exact Sciences stock? Company insiders (like executives and directors) hold about 1.23% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 86.48%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.